Dieses Video stammt von YouTube. Wir zeigen es hier zu Zwecken der Dokumentation. Den Inhalt bewerten wir nicht.
People with moderate-to-severe psoriasis can benefit from tildrakizumab (Ilumya), a biologic treatment that belongs to a class of drugs called interleukin-23 (IL-23) inhibitors. Biologics are protein-based medications that target specific parts of the immune system. IL-23 inhibitor specifically targets a type of cytokine called IL-23 and blocks cellular activity, which results in reduced inflammation that causes psoriasis.
4 Likes | Dislikes
Original: bei YouTube